Caricatures and drawings on Forex portal

Fitch downgrades Bayer’s rating with negative outlook

Open trading account

This information is provided to retail and professional clients as part of marketing communication. It does not contain and should not be construed as containing investment advice or investment recommendation or an offer or solicitation to engage in any transaction or strategy in financial instruments. Past performance is not a guarantee or prediction of future performance. Instant Trading EU Ltd. makes no representation and assumes no liability as to the accuracy or completeness of the information provided, or any loss arising from any investment based on analysis, forecast or other information provided by an employee of the Company or otherwise. Full disclaimer is available here.

Fitch downgrades Bayer’s rating with negative outlook

Offer your friend to read

Independent rating agency Fitch downgraded Bayer’s long-term issuer default rank to BBB+ from the previous A-. Analysts of Fitch Ratings gave Germany’s large pharmaceutical company the negative outlook.

Besides, the rank of Monsanto, Bayer’s agrochemical subsidiary, was revised downwards to BBB+ from A- by the same criterion. Interestingly, Fitch does not rule out a further deterioration in the rating. The reputation of the biotechnological division was undermined in 2019. Experts are clashing over the application of a glyphosate-based herbicide in the agriculture and irrational use of excessive investment. Such risks could enlarge the company’s operating margin, Fitch analysis suppose.

The negative outlook reflects a high risk of considerable expenses under the lawsuit on glyphosate. Fitch analysts are ready to upgrade the outlook to stable only on condition that the legal proceedings end up with the positive ruling. However, Bayer’s credit rating will be unaffected by any court decision, Fitch made a comment.

Monsanto’s long-term rating at the BBB+ level confirms the company’s top-notch status in the market and the elaborated financial policy that requires its management to cap dividends by €12 billion in 2019 – 2022.

Back